NEU_INS_STIMULATOR

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2016-12-16 for NEU_INS_STIMULATOR manufactured by Medtronic Neuromodulation.

Event Text Entries

[62669925] Date of event: please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature. A good faith effort will be made to obtain the applicable information relevant to the report. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[62669926] Polosan, m. , chabardes, s. , bougerol, t. , ardouin, c. , pollak, p. , benabid, al. , krack, p. Long-term improvement in obsessions and c ompulsions with subthalamic stimulation. Neurology. 2016;87(17):1843-1844. Summary: obsessive-compulsive disorder (ocd) may be conceptualized as a disorder of self-control and behavioral inhibition. Recent studies suggested interest in deep brain stimulation (dbs) of different subcortical brain targets such as the nucleus accumbens, anterior internal capsule/ventral striatum, and subthalamic nucleus (stn) in severe, resistant ocd. Stn is a critical node of the indirect and hyperdirect basal ganglia? Thalamocortical circuit. Stn-dbs may release its function as a brake on behavioral programs, disinhibiting habitual responses and enabling more flexible goal-directed behavior control in ocd. Little is known about long-term outcome of stn-dbs in ocd. Based on experience in parkinson disease, stn-dbs can induce a change from apathetic to disinhibited behavior. This target has also a potential impact on addictions. (b)(4). Reported event: a (b)(6) man with bilateral subthalamic nucleus deep brain stimulation (stn-dbs) for the treatment of obsessive compulsive disorder (ocd) overall had a major improvement in ocd, anxiety and mood and they were able to reintegrate into their social, family and work life. The patient reportedly experienced a major improvement in preexisting suicidal ideas, but made 2 suicidal attempts? In a context of short, partial relapses? Where he stopped taking his medication in the first year of implant. Ultimately after 10 years of implant the authors reported robust improvement that the patient self-estimated to be 80% compared to baseline. It was not possible to ascertain specific device information from the article or to match the reported event with any previously reported event.
Patient Sequence No: 1, Text Type: D, B5


[100825485] If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3007566237-2016-04440
MDR Report Key6182480
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2016-12-16
Date of Report2016-12-16
Date of Event2016-10-25
Date Mfgr Received2016-11-21
Date Added to Maude2016-12-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDIANE WOLF
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635263987
Manufacturer G1MEDTRONIC NEUROMODULATION
Manufacturer Street800 53RD AVE NE
Manufacturer CityMINNEAPOLIS MN 554211200
Manufacturer CountryUS
Manufacturer Postal Code554211200
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Product CodeMFR
Date Received2016-12-16
Model NumberNEU_INS_STIMULATOR
Catalog NumberNEU_INS_STIMULATOR
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROMODULATION
Manufacturer Address800 53RD AVE NE MINNEAPOLIS MN 554211200 US 554211200


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening 2016-12-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.